FAP and familial pancreatic carcinoma: A proof-of-concept study of 225Ac-FAPI-04 (as well as 64Cu-FAPI-04) in FAP-expressing pancreatic cancer xenograft mouse models suggested the applicability of FAP-targeted α-therapy in pancreatic cancer (31).